As of 2026-03-27, the Relative Valuation of Precigen Inc (PGEN) is (16.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.89 USD, the upside of Precigen Inc based on Relative Valuation is -517.5%.
The range of the Relative Valuation is (13.55) - (18.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 21.9x | 18.9x |
| Forward P/E multiples | 14.0x - 21.1x | 18.2x |
| Fair Price | (13.55) - (18.49) | (16.24) |
| Upside | -448.4% - -575.3% | -517.5% |
| Date | P/E |
| 2026-03-26 | -4.57 |
| 2026-03-25 | -3.54 |
| 2026-03-24 | -3.58 |
| 2026-03-23 | -3.70 |
| 2026-03-20 | -3.75 |
| 2026-03-19 | -3.79 |
| 2026-03-18 | -3.73 |
| 2026-03-17 | -4.04 |
| 2026-03-16 | -4.01 |
| 2026-03-13 | -4.01 |
| 2026-03-12 | -3.75 |
| 2026-03-11 | -3.91 |
| 2026-03-10 | -4.01 |
| 2026-03-09 | -4.01 |
| 2026-03-06 | -3.79 |
| 2026-03-05 | -3.85 |
| 2026-03-04 | -4.05 |
| 2026-03-03 | -3.85 |
| 2026-03-02 | -4.13 |
| 2026-02-27 | -4.33 |
| 2026-02-26 | -4.35 |
| 2026-02-25 | -4.39 |
| 2026-02-24 | -4.55 |
| 2026-02-23 | -4.66 |
| 2026-02-20 | -5.00 |
| 2026-02-19 | -5.15 |
| 2026-02-18 | -5.57 |
| 2026-02-17 | -5.95 |
| 2026-02-13 | -5.63 |
| 2026-02-12 | -5.41 |
| 2026-02-11 | -5.61 |
| 2026-02-10 | -5.32 |
| 2026-02-09 | -5.21 |
| 2026-02-06 | -4.90 |
| 2026-02-05 | -4.84 |
| 2026-02-04 | -5.21 |
| 2026-02-03 | -5.48 |
| 2026-02-02 | -5.52 |
| 2026-01-30 | -5.13 |
| 2026-01-29 | -5.17 |
| 2026-01-28 | -5.09 |
| 2026-01-27 | -5.40 |
| 2026-01-26 | -5.43 |
| 2026-01-23 | -5.44 |
| 2026-01-22 | -5.53 |
| 2026-01-21 | -5.09 |
| 2026-01-20 | -5.01 |
| 2026-01-16 | -5.04 |
| 2026-01-15 | -4.73 |
| 2026-01-14 | -5.04 |